| Title : Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model - Cagli_2021_Drug.Dev.Res__ |
| Author(s) : Cagli A , Senol SP , Temiz-Resitoglu M , Guden DS , Sari AN , Sahan-Firat S , Tunctan B |
| Ref : Drug Dev Res , : , 2021 |
| Abstract : Cagli_2021_Drug.Dev.Res__ |
| ESTHER : Cagli_2021_Drug.Dev.Res__ |
| PubMedSearch : Cagli_2021_Drug.Dev.Res__ |
| PubMedID: 33559150 |
Cagli A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B (2021)
Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model
Drug Dev Res
:
Cagli A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B (2021)
Drug Dev Res
: